SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-22-027644
Filing Date
2022-05-17
Accepted
2022-05-17 16:08:26
Documents
5

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT FILING ea160174-8k_biotech.htm 425 35196
2 PRESS RELEASE ea160174ex99-1_biotech.htm EX-99.1 29749
3 GRAPHIC image_001.jpg GRAPHIC 3019
4 GRAPHIC image_002.jpg GRAPHIC 2241
5 GRAPHIC image_003.gif GRAPHIC 1827
  Complete submission text file 0001213900-22-027644.txt   76559
Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Filed by) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001
Business Address 545 WEST 25TH STREET 20TH FLOOR NEW YORK NY 10001 8586920539
Biotech Acquisition Co (Subject) CIK: 0001825413 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39935 | Film No.: 22934513
SIC: 2834 Pharmaceutical Preparations